5402ST went up for sale at Sotheby's Paris Fine Watches Sale. It's impossible to count quite how many variations of Omega's defining ... But for the price, this is a worthy throwback.
Omega Therapeutics, Inc. (NASDAQ: OMGA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.50 per share a year ago.